Skip to menu Skip to content Skip to footer

2022

Journal Article

Factors that influence clinical trial participation by patients with cancer in Australia: a scoping review protocol

You, Kyung Ha, Lwin, Zarnie, Ahern, Elizabeth, Wyld, David and Roberts, Natasha (2022). Factors that influence clinical trial participation by patients with cancer in Australia: a scoping review protocol. BMJ open, 12 (4) e057675, e057675. doi: 10.1136/bmjopen-2021-057675

Factors that influence clinical trial participation by patients with cancer in Australia: a scoping review protocol

2022

Journal Article

Scoping to analyze oncology trial participation in Australia

You, Kyung Ha, Ahern, Elizabeth, Wyld, David, Lwin, Zarnie and Roberts, Natasha (2022). Scoping to analyze oncology trial participation in Australia. Seminars in Oncology, 49 (2), 178-181. doi: 10.1053/j.seminoncol.2022.04.003

Scoping to analyze oncology trial participation in Australia

2022

Journal Article

The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosis

Guccione, Lisa, Gough, Karla, Drosdowsky, Allison, Price, Timothy, Pavlakis, Nick, Wyld, David, Ransom, David, Michael, Michael and Schofield, Penelope (2022). The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosis. Patient Education and Counseling, 105 (1), 212-220. doi: 10.1016/j.pec.2021.05.006

The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosis

2021

Journal Article

Equity across the cancer care continuum for culturally and linguistically diverse migrants living in Australia: a scoping review

Scanlon, Brighid, Brough, Mark, Wyld, David and Durham, Jo (2021). Equity across the cancer care continuum for culturally and linguistically diverse migrants living in Australia: a scoping review. Globalization and Health, 17 (1) 87, 87. doi: 10.1186/s12992-021-00737-w

Equity across the cancer care continuum for culturally and linguistically diverse migrants living in Australia: a scoping review

2021

Journal Article

The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trial

Molassiotis, Alex, Brown, Teresa, Cheng, Hui Lin, Byrnes, Angela, Chan, Raymond Javan, Wyld, David, Eastgate, Melissa, Yates, Patsy, Marshall, Andrea P, Fichera, Rebecca, Isenring, Liz, To, Ki Fung, Ko, Po Shan, Lam, Wang, Lam, Yuk Fong, Au, Lai Fan and Lo, Raymond See-kit (2021). The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trial. Nutrition Journal, 20 (1) 2, 2. doi: 10.1186/s12937-020-00657-2

The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trial

2021

Journal Article

Our experience of nursing/allied health practitioner led geriatric screening and assessment of older patients with cancer – a highly accessible model of care

Thaker, Darshit Arunbhai, McGuire, Peter, Bryant, Geoffrey, Wyld, David, Leach, Justine, Wheatley, Hermione, Snape-Jenkinson, Stella, Kelly, Bernadette, Bourke, Anne and Kennedy, Glen (2021). Our experience of nursing/allied health practitioner led geriatric screening and assessment of older patients with cancer – a highly accessible model of care. Journal of Geriatric Oncology, 12 (8), 1186-1192. doi: 10.1016/j.jgo.2021.05.003

Our experience of nursing/allied health practitioner led geriatric screening and assessment of older patients with cancer – a highly accessible model of care

2021

Journal Article

Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours

Elston, Marianne S., Love, Amanda, Kevat, Dev, Carroll, Richard, Siow, Zhen Rong, Pattison, Sharon, Boyle, Veronica, Segelov, Eva, Strickland, Andrew H., Wyld, David, Gauci, Richard, Kennedy, Kim and Ransom, David (2021). Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours. Cancer Medicine, 10 (23), 8405-8411. doi: 10.1002/cam4.4345

Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours

2021

Journal Article

Preclinical molecular PET-CT imaging targeting CDCP1 in colorectal cancer

Cuda, Tahleesa J., He, Yaowu, Kryza, Thomas, Khan, Tashbib, Tse, Brian W., Sokolowski, Kamil A., Liu, Cheng, Lyons, Nicholas, Gough, Madeline, Snell, Cameron E., Wyld, David K., Rose, Stephen, Riddell, Andrew D., Stevenson, Andrew R. L., Thomas, Paul A., Clark, David A., Puttick, Simon and Hooper, John D. (2021). Preclinical molecular PET-CT imaging targeting CDCP1 in colorectal cancer. Contrast Media and Molecular Imaging, 2021 3153278, 3153278. doi: 10.1155/2021/3153278

Preclinical molecular PET-CT imaging targeting CDCP1 in colorectal cancer

2021

Journal Article

Prospective cohort study of an Australian cancer care services-led model of emergent care

Button, Elise, Gavin, Nicole C., Bates, Tracey, Ahmed, Deka, Nasato, Gillian, Wyld, David, Kennedy, Glen, Fennelly, Eileen, Smith, Michael, Northfield, Sarah and Yates, Patsy (2021). Prospective cohort study of an Australian cancer care services-led model of emergent care. Australian Health Review, 45 (5), 613-621. doi: 10.1071/AH20346

Prospective cohort study of an Australian cancer care services-led model of emergent care

2021

Conference Publication

177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with somatostatin-expressing neuroendocrine tumors: a real-world retrospective review of efficacy and safety from an Australian tertiary cancer Center

Nalder, Mark, Ladwa, Rahul, Raina, Anant, Burge, Matthew E., Love, Amanda, Pattison, David A., Ramsay, Stuart and Wyld, David (2021). 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with somatostatin-expressing neuroendocrine tumors: a real-world retrospective review of efficacy and safety from an Australian tertiary cancer Center. 2021 ASCO Annual Meeting I, Virtual, 4-8 June 2021. Alexandria, VA USA: American Society of Clinical Oncology. doi: 10.1200/jco.2021.39.15_suppl.e16198

177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with somatostatin-expressing neuroendocrine tumors: a real-world retrospective review of efficacy and safety from an Australian tertiary cancer Center

2021

Journal Article

Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia

Gasper, Harry, Ahern, Elizabeth, Roberts, Natasha, Chan, Bryan, Hughes, Brett, Kennedy, Glen, Wyld, David, Eastgate, Melissa and Lwin, Zarnie (2021). Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia. BMJ Open, 11 (5) e044655, e044655. doi: 10.1136/bmjopen-2020-044655

Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia

2021

Journal Article

Resilience and ongoing quality care for cancer clinical trials during COVID-19: experience from a tertiary hospital in Australia

Ives, Amy, Pusztai, Tricia, Keller, Jacqui, Ahern, Elizabeth, Chan, Bryan, Gasper, Harry, Wyld, David, Kennedy, Glen, Dickie, Graeme, Lwin, Zarnie and Roberts, Natasha A. (2021). Resilience and ongoing quality care for cancer clinical trials during COVID-19: experience from a tertiary hospital in Australia. Asia-Pacific Journal of Clinical Oncology, 18 (2), e141-e147. doi: 10.1111/ajco.13570

Resilience and ongoing quality care for cancer clinical trials during COVID-19: experience from a tertiary hospital in Australia

2021

Journal Article

Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): the NETPET score as a prognostic biomarker

Chan, David L., Ulaner, Gary A., Pattison, David A., Wyld, David, Ladwa, Rahul, Kirchner, Julian, Li, Bob T, Lai, W Victoria, Pavlakis, Nick, Roach, Paul J and Bailey, Dale L (2021). Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): the NETPET score as a prognostic biomarker. Journal of Nuclear Medicine, 62 (9), 1278-1284. doi: 10.2967/jnumed.120.257659

Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): the NETPET score as a prognostic biomarker

2021

Journal Article

Hemoglobin, body mass index, and age as risk factors for Paclitaxel- and Oxaliplatin-induced peripheral neuropathy

Mizrahi, David, Park, Susanna B., Li, Tiffany, Timmins, Hannah C., Trinh, Terry, Au, Kimberley, Battaglini, Eva, Wyld, David, Henderson, Robert D., Grimison, Peter, Ke, Helen, Geelan-Small, Peter, Marker, Julie, Wall, Brian and Goldstein, David (2021). Hemoglobin, body mass index, and age as risk factors for Paclitaxel- and Oxaliplatin-induced peripheral neuropathy. JAMA Network Open, 4 (2) e2036695, 1-14. doi: 10.1001/jamanetworkopen.2020.36695

Hemoglobin, body mass index, and age as risk factors for Paclitaxel- and Oxaliplatin-induced peripheral neuropathy

2021

Journal Article

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Kang, Eun Young, Cheasley, Dane, LePage, Cecile, Wakefield, Matthew J., da Cunha Torres, Michelle, Rowley, Simone, Salazar, Carolina, Xing, Zhongyue, Allan, Prue, Bowtell, David D. L., Mes-Masson, Anne-Marie, Provencher, Diane M., Rahimi, Kurosh, Kelemen, Linda E., Fasching, Peter A., Doherty, Jennifer A., Goodman, Marc T., Goode, Ellen L., Deen, Suha, Pharoah, Paul D. P., Brenton, James D., Sieh, Weiva, Mateoiu, Constantina, Sundfeldt, Karin, Cook, Linda S., Le, Nhu D., Anglesio, Michael S., Gilks, C. Blake, Huntsman, David G. ... Campbell, Ian G. (2021). Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses. Modern Pathology, 34 (1), 194-206. doi: 10.1038/s41379-020-0618-9

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

2021

Journal Article

Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015

Wyld, David, Moore, Julie, Tran, Nancy and Youl, Philippa (2021). Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015. Asia-Pacific Journal of Clinical Oncology, 17 (4), 350-358. doi: 10.1111/ajco.13503

Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015

2020

Journal Article

PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancer

Cuda, Tahleesa J., Riddell, Andrew D., Liu, Cheng, Whitehall, Vicki L., Borowsky, Jennifer, Wyld, David K., Burge, Matthew E., Ahern, Elizabeth, Griffin, Alison, Lyons, Nicholas J. R., Rose, Stephen E., Clark, David A., Stevenson, Andrew R. L., Hooper, John D., Puttick, Simon and Thomas, Paul A. (2020). PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancer. The Journal of Nuclear Medicine, 61 (11), 1576-1579. doi: 10.2967/jnumed.119.233312

PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancer

2020

Journal Article

Statistical Process Control assessed implementation fidelity of Patient Reported Outcome Measures (PROMs) in routine care

Roberts, Natasha A., Alexander, Kimberly, Wyld, David and Janda, Monika (2020). Statistical Process Control assessed implementation fidelity of Patient Reported Outcome Measures (PROMs) in routine care. Journal of Clinical Epidemiology, 127, 76-86. doi: 10.1016/j.jclinepi.2020.06.022

Statistical Process Control assessed implementation fidelity of Patient Reported Outcome Measures (PROMs) in routine care

2020

Journal Article

The utility of the implementation science framework “Integrated Promoting Action on Research Implementation in Health Services” (i-PARIHS) and the facilitator role for introducing patient-reported outcome measures (PROMs) in a medical oncology outpatient department

Roberts, Natasha A., Janda, Monika, Stover, Angela M., Alexander, Kimberly E., Wyld, David and Mudge, Alison (2020). The utility of the implementation science framework “Integrated Promoting Action on Research Implementation in Health Services” (i-PARIHS) and the facilitator role for introducing patient-reported outcome measures (PROMs) in a medical oncology outpatient department. Quality of Life Research, 30 (11), 3063-3071. doi: 10.1007/s11136-020-02669-1

The utility of the implementation science framework “Integrated Promoting Action on Research Implementation in Health Services” (i-PARIHS) and the facilitator role for introducing patient-reported outcome measures (PROMs) in a medical oncology outpatient department

2020

Journal Article

Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: a population-based analysis

McGahan, William, Waterhouse, Mary A., O'Connell, Dianne L., Merrett, Neil D., Goldstein, David, Wyld, David, Burmeister, Elizabeth A., Jordan, Susan J. and Neale, Rachel E. (2020). Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: a population-based analysis. Pancreatology, 20 (7), 1458-1464. doi: 10.1016/j.pan.2020.07.405

Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: a population-based analysis